INFUSION CARE
THAT PRIORITIZES
YOU
Effective October 15th, the New York Medicare administrator, NGS, added STELARA® J3357 (pre-filled syringe and 45-mg vial) to their Self-Administered Drug list. This change means that patients receiving Stelara injections are not able to have these services covered under Medicare Part B.
Specialty Infusion is working with QuickRx pharmacy to service Medicare patients that are impacted by this change and provide continuity of care at our locations under Medicare Part D. We are also able to accommodate new Medicare patients that have been displaced from their normal injection site. Please contact us or have your physician prescribe here to QuickRx if you are interested in receiving Stelara injections at our Specialty Infusion locations.
Why Use Specialty Infusion Centers?
Interested in Speaking with Someone at a Specialty Infusion Center Near You?
Offering a Wide Range of
Infusion and Injection Treatments
- ADAKVEO
- ADUHELM
- Benlysta
- Cimzia
- Entyvio
- Fabrazyme
- Fasenra
- Gammagard
- Gamunex-C
- Givlaari
- Hizentra
- Inflectra
- Intralipid
- Krystexxa
- Lemtrada
- NAD+
- Nulojix
- Ocrevus
- Onpattro
- Orencia
- Privigen
- Radicava
- Remicade
- Renflexis
- Rituxan
- Simponi Aria
- Soliris
- Solu-Medrol
- Stelara IV
- Stelara SQ
- TEPEZZA
- Tysabri
- Uplizna
- VPRIV
- VYVGART
- Xolair
Featured Blog Posts
Sickle Cell Disease Symptoms and Treatments
6/30/2022
Sickle cell disease manifests as a genetic blood condition known as sickle cell anemia. Each person’s symptoms are unique & evolve gradually.
Chronic Gout: Symptoms and Treatments
6/23/2022
Gout is arthritis that affects the joints & produces severe pain, swelling, & stiffness. Learn more about Chronic Gout symptoms & treatments.